Pharmaceutical and Medical Device
King & Spalding’s Pharmaceutical & Medical Device practice is consistently recognized as among the best in the nation. Our knowledge of the industry, combined with our broad capabilities and a deep bench of first-chair trial attorneys, allow us to handle any aspect of drug and device litigation, from early case assessment, through discovery, and on to trial and exit strategies.
February 20, 2024
FDA Issues Draft Guidance on Use of Data Monitoring Committees in Clinical Trials
February 8, 2024
FDA Aligns U.S. Medical Device Quality System Regulation with International Standards
January 10, 2024
FDA Issues Proposed Rule Classifying Certain Wound Dressings and Liquid Wound Washes For the First Time
March 6, 2024
Ursula Henninger Inducted Into American College of Trial Lawyers
February 26, 2024
Trial Partner Veronica Moyé Joins King & Spalding as Firm Opens New Office in Dallas
February 28, 2024
King & Spalding Secures a Dismissal of False Claims Act Complaint against Senseonics Incorporated
May 2, 2023
Dutscher group to acquire Ozyme in France